Revolutionizing Biomedical Research

Early detection and accurate diagnosis are imperative for delivering optimal treatment to patients. Thanks to technology developed by the UNC Center for Computer-Integrated Systems for Microscopy and Manipulation, individualized diagnostics are moving from the bench to the clinic to the bedside.

This technology is being commercialized by Redbud Labs, a microfluidic chip manufacturer founded by Carolina faculty and alumni. Redbud’s patented technology allows precise manipulation of cells to advance biological research more quickly, efficiently and economically.

Redbud’s new microfluidic mixing technology, called MXR, enables scientists to perform point-of-care molecular diagnostics, analyzing thousands of genes simultaneously at speeds up to 10 times faster than traditional methods. MXR is the world’s first microfluidic mixing module designed specifically for use with diagnostic products.

This technology is revolutionary and has the potential to dramatically affect biomedical research.

Read the complete Carolina Story…

Related Stories

Siblings Guide the Next Generation

Teaching Beyond the Scope of a Classroom

Southern voices, future leaders